SC
Sachin Chaturvedi
National Institute of Pharmaceutical Education and Research, Gland Pharma Ltd
Employment
-
National Institute of Pharmaceutical Education and Research Phd. Research Scholar2022 - Present
-
Gland Pharma Ltd JR. RESEARCH ASSOCIATE2021 - 2022
-
National Institute of Pharmaceutical Education and Research M.S. Research Scholor2019 - 2021
Education
-
National Institute of Pharmaceutical Education and Research MS. PHARM
Projects & Funding
Projects & funding information is unavailable.
Publications (10)
- A targeted partial reduction cyanylation strategy coupled with HRMS for accurate disulfide bridge mapping in disulfide rich cyclic peptides Save
- Simultaneous Quantification of Apremilast and Leflunomide Using Reversed Phase High‑Performance Liquid Chromatography Method in Nano‐Liposomal Convoy: Formulation Optimization, Force Degradation Studies, and Greenness Evaluation Save
- High-Resolution LC–MS Approach for Structural Elucidation and (Q)SAR-Based Toxicity Assessment of Cyclic Peptide Lanreotide Acetate Degradation Products Save
- Advances in mass spectrometry for metabolomics: Strategies, challenges, and innovations in disease biomarker discovery Save
- Development and validation of RP-HPLC method for simultaneous estimation of 5-fluorouracil and silibinin in corn-derived protein-polysaccharide nanocomplex: Forced degradation and mathematical modeling of drug release Save
- Drug-Leachable Interaction Product Evaluation in Prefilled Syringe of Ganirelix Acetate Injection Save
- LC/Q‐TOF‐MS‐based structural characterization of enasidenib degradation products and establishment of a stability‐indicating assay method: Insights into chemical stability Save
- Recent advancements in disulfide bridge characterization: Insights from mass spectrometry Save
- Current analytical approaches for characterizing nanoparticle sizes in pharmaceutical research Save
- Development and validation of sensitive high‐performance liquid chromatography‐photodiode array method for determination of three sulfonated esters and N‐methyl‐O‐phenyldiamine dihydrochloride as potential genotoxic impurities in Amlodipine and Telmisart… Save